In the present study, we generates a diabetic rat model treated with HFD plus low-dose STZ and focuses on the role of SIK1 in the hepatic gluconeogenic and lipogenic pathways and their effect on the resulting phenotype of lower fasting glucose levels and ameliorated fatty liver disease. The gene discussed is SIK1; the disease is fatty liver disease.